Your institution may have access to this item. Find your institution then sign in to continue.
Title
Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
Authors
Joshua, F F; Oakley, S P; Major, G A
Abstract
Anti-inflammatory medications are the most common treatment for rheumatic disease in Australia. Recent years have seen large increases in the use of selective cyclooxygenase-2 (COX-2) inhibitors. Predictors of use, costs and benefits of the new medications have not been evaluated.
Publication
Internal medicine journal, 2004, Vol 34, Issue 4, p153